Genmab US, Inc.
Time frame: 1 January 2023 - 31 December 2023Article ‘Count’ and ‘Share’ for Genmab US, Inc. based on listed parameters only.
The articles listed below published by authors from Genmab US, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
American Journal of Pathology |
1 | 0.17 |
Journal of Clinical Oncology |
2 | 0.11 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.